May 26, 2008
ASKLEP & XClinical joint exhibit at CDISC Conference in Tokyo, June 5th and 6th
ASKLEP Inc., a Japan based CRO providing clinical research services and XClinical, a European vendor of innovative software products for e-clinical trials, today announced its joint participation at the CDISC Conference in Tokyo, Japan, to be held on June 5th & 6th.
XClinical will exhibit together with Asklep, its Japanese partner and one of the leading CROs in the country. ASKLEP has been collaborating with XClinical to bring XClinical's Marvin 2.0 EDC system to the Japanese clinical trial market.
At this CDISC conference, XClinical will be leading the ODM Training course on Tuesday, June 3rd as well as the session titled, "End-to-End Processing - A presentation of CDISC certified tools and their benefits in clinical research".
"ASKLEP is the first Japanese CRO to join CDISC and having a CDISC ODM Certified partner like XClinical certainly speeds up our goal for having a global standard EDC solution for our clients here in Japan" said Toshio Yoshii, Ph.D., and Director of Clinical Information Division at ASKLEP.
About ASKLEP
Asklep, Inc., (http://www.asklep.co.jp) founded in 1992, in Tokyo, Japan, provides clinical research services in monitoring, data management, biostatistics, regulatory & consulting, CRA training, etc. ASKLEP is an INTAGE Group Company. INTAGE, INC., (http://www.intage.co.jp) is the largest marketing research company in Japan and the eleventh largest globally. It has one of the most comprehensive healthcare solution services in the industry
About XClinical GmbH
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM). Till today, MARVIN was used to collect and process data of more than 50,000 patients in 50+ studies.
Contact: ASKLEP Corporate Planning and Development Dept. Tel: 81-3-5294-5223
